Extended exhaled nitric oxide measurements at different exhalation flows may differentiate between bronchial airways and alveolar inflammation in patients with asthma and COPD Source: Eur Respir J 2002; 20: Suppl. 38, 174s Year: 2002
Differential assessment of airway inflammation in chronic obstructive pulmonary disease (COPD) by measurements of exhaled nitric oxide (NO) derived from peripheral vs. central airways Source: Eur Respir J 2003; 22: Suppl. 45, 279s Year: 2003
Increased nitrosative stress in COPD airways: validation and measurement in exhaled breath condensate Source: Annual Congress 2009 - COPD: from biomarker profiling to clinical assessment Year: 2009
Differential assessment of airway inflammation and anti-inflammatory treatment in asthma by measurements of exhaled nitric oxide (NO) derived from peripheral versus central airways Source: Eur Respir J 2003; 22: Suppl. 45, 449s Year: 2003
Noninvasive biomarkers of airway inflammation and oxidative stress in the exhaled breath of patients with bronchial asthma Source: Eur Respir J 2003; 22: Suppl. 45, 371s Year: 2003
Noninvasive estimation of inflammation and remodelling Source: Annual Congress 2006 - PG4 - Asthma: pathology and treatment Year: 2006
Characterization of allergic airway inflammation in patients with COPD using fractional exhaled nitric oxide levels Source: Annual Congress 2013 –Assessment of airway inflammation by exhaled gases Year: 2013
Non invasive monitoring of airway inflammation in EBC and exhaled air is more sensitive than pulmonary function testing Source: Eur Respir J 2005; 26: Suppl. 49, 509s Year: 2005
Noninvasive assessment of airway inflammation in asthma Source: ISSN=1025-448x, ISBN=1-904097-26-x, page=164 Year: 2003
Differential measurement of exhaled breath temperature allows characterization of the spread of inflammation in airways diseases Source: International Congress 2019 – Evaluation of basic science in airway diseases Year: 2019
Nitric oxide metabolites (NOx) in exhaled breath condensate as a non-invasive marker of airway inflammation in infants with cystic fibrosis. Comparisons with bronchoalveolar lavage findings Source: Eur Respir J 2004; 24: Suppl. 48, 157s Year: 2004
Exhaled air molecular profiling in relation to inflammatory subtype and activity in COPD Source: Eur Respir J 2011; 38: 1301-1309 Year: 2011
Inhibition of reactive nitrogen species production in COPD airways: comparison between steroid and theophylline Source: Eur Respir J 2005; 26: Suppl. 49, 293s Year: 2005
Non invasive assessment of airway inflammation by exhaled markers in EBC, sputum and NO Source: Eur Respir J 2004; 24: Suppl. 48, 578s Year: 2004
Analysis of reactive oxygen species in sputum neutrophils during acute exacerbation of COPD Source: Annual Congress 2012 - Inflammatory mechanisms in COPD Year: 2012
Aerobic exercise reduces airway inflammation, remodeling and hyperresponsiveness by inhibiting reactive oxygen species and TGF-beta production by activated airway leukocytes: a flow cytometry approach Source: International Congress 2018 – Identification of therapeutic targets for asthma Year: 2018
Measurement of bronchial and peripheral airway nitric oxide production by multiple exhalation flow rates in children with PCD Source: Eur Respir J 2005; 26: Suppl. 49, 226s Year: 2005
Measurement of exhaled gases in chronic airway diseases Source: International Congress 2017 – PG6 Assessing and monitoring airway inflammation in asthma and chronic obstructive pulmonary disease Year: 2017
Repeated eNose assessment in the monitoring of O2 -induced changes in exhaled breath metabolites in COPD Source: Annual Congress 2008 - New frontiers in noninvasive assessment of the lungs Year: 2008
Prediction of CF exacerbations by FeNO and non-invasive inflammatory markers in exhaled breath condensate Source: Annual Congress 2008 - Cystic fibrosis: novel aspects of airway function and inflammation Year: 2008